Click on the links below for details on previous studies conducted by the Jacob Lab
Intranasal Oxytocin for the Treatment of Children and Adolescents with Autism Spectrum Disorders (ASD) – Ages 10-17 - Enrollment Full
Single Dose Intranasal Oxytocin (IN-OT) Versus Placebo in Autism: Examining the Cognitive Effects – Ages 5-40 - Enrollment Full
FaceStation – Ages 12-17 males - Enrollment Full
Imaging Study - Ages 8-17 - Enrollment Full